A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Pliant Therapeutics, Inc.
Pliant Therapeutics, Inc.
Instituto do Cancer do Estado de São Paulo
EvolveImmune United, Inc
OncoC4, Inc.
National Institutes of Health Clinical Center (CC)
Sotio Biotech Inc.
Rutgers, The State University of New Jersey
Rutgers, The State University of New Jersey
MacroGenics
Novartis
University of Pittsburgh
Incyte Corporation
Sahlgrenska University Hospital
Washington University School of Medicine
Jonsson Comprehensive Cancer Center
Shattuck Labs, Inc.
SOLTI Breast Cancer Research Group
UNICANCER
Shanghai Bovax Biotechnology Co., Ltd.
University of Maryland, College Park
The Affiliated Hospital of Qingdao University
SCG Cell Therapy Pte. Ltd.
M.D. Anderson Cancer Center
Gene Surgery LLC
Shanghai Bovax Biotechnology Co., Ltd.
University of Maryland, College Park
HRYZ Biotech Co.
HRYZ Biotech Co.
Charite University, Berlin, Germany
M.D. Anderson Cancer Center
Xencor, Inc.
National Institutes of Health Clinical Center (CC)
Xencor, Inc.
Genocea Biosciences, Inc.
Institut de Cancérologie de Lorraine
Karolinska Institutet
AIDS Malignancy Consortium
Abramson Cancer Center at Penn Medicine
Boston Medical Center
University of Iowa
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Oryx GmbH & Co. KG
National Cancer Institute (NCI)
Alliance for Clinical Trials in Oncology
City of Hope Medical Center
Emory University
National Cancer Institute (NCI)
Dartmouth-Hitchcock Medical Center
INSYS Therapeutics Inc